Article info
PDFShort report
Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathology
- Correspondence to Dr Gerardo Ferrara, Anatomic Pathology, Hospital of Macerata, Macerata I62100, Italy; gerardo.ferrara{at}libero.it
Citation
Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathology
Publication history
- Received June 3, 2020
- Revised June 9, 2020
- Accepted June 10, 2020
- First published June 19, 2020.
Online issue publication
February 18, 2021
Article Versions
- Previous version (19 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage